These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1711186)

  • 1. HMB-45 immunohistochemical staining of conjunctival melanocytic lesions.
    McDonnell JM; Sun YY; Wagner D
    Ophthalmology; 1991 Apr; 98(4):453-8. PubMed ID: 1711186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
    Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
    Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential immunoreactivity of melanocytic lesions of the conjunctiva.
    Sharara NA; Alexander RA; Luthert PJ; Hungerford JL; Cree IA
    Histopathology; 2001 Oct; 39(4):426-31. PubMed ID: 11683945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
    Steuhl KP; Rohrbach JM; Knorr M
    Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical studies of atypical conjunctival melanocytic nevi.
    Jakobiec FA; Colby K; Bajart AM; Saragas SJ; Moulin A
    Arch Ophthalmol; 2009 Aug; 127(8):970-80. PubMed ID: 19667333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation.
    Skelton HG; Smith KJ; Barrett TL; Lupton GP; Graham JH
    Am J Dermatopathol; 1991 Dec; 13(6):543-50. PubMed ID: 1725245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions.
    Reddy HS; Keene CD; Chang SH; Jian-Amadi A; Cimino PJ
    Exp Mol Pathol; 2017 Apr; 102(2):198-202. PubMed ID: 28161440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMB-45 antibody reactivity in pigmented lesions of the conjunctiva.
    Glasgow BJ; McCall LC; Foos RY
    Am J Ophthalmol; 1990 Jun; 109(6):696-700. PubMed ID: 2189315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens.
    Novais GA; Fernandes BF; Belfort RN; Castiglione E; Cheema DP; Burnier MN
    Int J Surg Pathol; 2010 Feb; 18(1):60-3. PubMed ID: 18611943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine Receptor Expression Pattern Correlates to Progression of Conjunctival Melanocytic Lesions.
    van Ipenburg JA; de Waard NE; Naus NC; Jager MJ; Paridaens D; Verdijk RM
    Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):2950-2957. PubMed ID: 31305861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
    Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
    Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocytic lesions of the conjunctiva.
    Zembowicz A; Mandal RV; Choopong P
    Arch Pathol Lab Med; 2010 Dec; 134(12):1785-92. PubMed ID: 21128776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.
    Soon AK; Brownstein S; Tang T; Saleh S; Jiang K; Levac J; Blanco P; Farmer J
    Can J Ophthalmol; 2019 Dec; 54(6):699-707. PubMed ID: 31836103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
    Heegaard S; Jensen OA; Prause JU
    Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo confocal microscopy of pigmented conjunctival tumors.
    Messmer EM; Mackert MJ; Zapp DM; Kampik A
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1437-45. PubMed ID: 16598465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival Primary Acquired Melanosis: Is It Time for a New Terminology?
    Jakobiec FA
    Am J Ophthalmol; 2016 Feb; 162():3-19.e1. PubMed ID: 26556007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16ink4a expression in benign and malignant melanocytic conjunctival lesions.
    Zoroquiain P; Fernandes BF; González S; Novais GN; Schalper KA; Burnier MN
    Int J Surg Pathol; 2012 Jun; 20(3):240-5. PubMed ID: 22287653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
    Seregard S; Oskarsson M; Spângberg B
    Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential diagnosis and management of melanocytic lesions of the ocular surface].
    Tóth G; Szalai E; Csákány B; Hécz R; Sándor GL; Lukáts O; Nagy ZZ; Szentmáry N
    Orv Hetil; 2020 Apr; 161(15):563-574. PubMed ID: 32320191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.